February 1, 2017
Curetis’ Global Installed Base Expanding to Over 150 Unyvero Analyzers – Completion of EMEA Direct Sales team build-out drives 46% growth in system installations over the […]
January 12, 2017
Journal of “Cancer Treatment and Research Communications” Publishes Results of Study with Blood Test Epi proColon® ADMIT Study Results Demonstrate Higher Uptake of a Colorectal Cancer […]
January 11, 2017
January 5, 2017
Curetis Files for U.S. FDA Clearance for Unyvero Platform and LRT Application Cartridge – Final panel demonstrates overall weighted average sensitivity of 91.4% and overall weighted […]
January 4, 2017
Curetis Completes Development of Unyvero Cartridge for Intra-Abdominal Infections – Highly multiplexed panel covers up to 112 diagnostic targets – Third new panel developed within one […]
December 14, 2016
Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec – Gyronimo Platform offers rapid, quantitative cartridge-based sample-to-answer molecular diagnostic testing – Gyronimo to be fully integrated […]
November 8, 2016
ARUP Laboratories to Offer Epi proColon®, Epigenomics’ Blood-Based Colorectal Cancer Screening Test (Press Release) Berlin (Germany) and Germantown, MD (U.S.A.), November 8, 2016 – Epigenomics AG […]
October 27, 2016
USPSTF Guidelines May Have Used Old Data on Epigenomics Colorectal Cancer Screening Test Oct 26, 2016 NEW YORK (GenomeWeb) – The US Preventive Services Task Force […]
October 25, 2016
Curetis Announces Positive Top Line Data from U.S. FDA Trial – Primary endpoint for Unyvero LRT product for lower respiratory tract infections shows overall weighted average […]
